C-proSP-B: A Possible Biomarker for Pulmonary Diseases? | Zendy

Nicolas Kahn | Zendy; Anne-Kathrin Rossler | Zendy; Katrin Hornemann | Zendy; Thomas Muley | Zendy; Ekkehard Grünig | Zendy; Werner Schmidt | Zendy; Felix J.F. Herth | Zendy; Michael Kreuter | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

C-proSP-B: A Possible Biomarker for Pulmonary Diseases?

Author(s) -

Nicolas Kahn,

Anne-Kathrin Rossler,

Katrin Hornemann,

Thomas Muley,

Ekkehard Grünig,

Werner Schmidt,

Felix J.F. Herth,

Michael Kreuter

Publication year - 2018

Publication title -

respiration

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.264

H-Index - 81

eISSN - 1423-0356

pISSN - 0025-7931

DOI - 10.1159/000488245

Subject(s) - medicine , biomarker , pulmonary function testing , idiopathic pulmonary fibrosis , lung , lung cancer , interstitial lung disease , pulmonary fibrosis , gastroenterology , immunology , pathology , biochemistry , chemistry

Detection of surfactant proteins A and D (SP-A and SP-D) in the serum of patients with pulmonary diseases is thought to reflect an injury of the alveolar epithelial barrier and as such serve as a biomarker for these diseases. However, the data for SP-B are limited.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research